Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
Recursion, a clinical stage TechBio company listed on Nasdaq, announced the Compensation Committee's approval of inducement restricted stock units (RSUs) totaling nearly 3 million shares granted to 33 new employees under its 2024 Inducement Equity Incentive Plan. The awards vest over a multi-year schedule and are intended to incentivize employee co…